Jpmorgan Chase & Co »

Omega Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Omega Therapeutics (OMGA) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Omega Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Omega Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Omega Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $48k 16k 3.01
2023-09-30 $56k 26k 2.15
2023-06-30 $119k 21k 5.60
2023-03-31 $10k 1.7k 5.94
2022-12-31 $9.0k 1.6k 5.78
2022-06-30 $7.0k 1.9k 3.68
2022-03-31 $113k 18k 6.22
2021-12-31 $102k 9.0k 11.30